SWOG clinical trial number
CTSU/A011401

Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer (BWEL)

Closed
Phase
Abbreviated Title
Breast Cancer WEight Loss Study (BWEL Study)
Status Notes
Permanently closed to accrual, effective 02/15/2021.
This study is active in SWOG effective 4/1/17.
Activated
08/26/2016
Closed
02/15/2021

Research committees

Breast Cancer
Symptom Control and Quality of Life

Eligibility Criteria Expand/Collapse

Eligibility criteria are accessible from the protocol abstract page on the CTSU website (http://www.ctsu.org).

Publication Information Expand/Collapse

2022

The Breast Cancer Weight Loss (BWEL) Trial (Alliance 011401): A Description of the Lifestyle Intervention

L Delahanty;T Wadden;P Goodwin;C Alfano;C Thomson;M Irwin;M Neuhouser;T Crane;E Frank;P Spears;B Gillis;D Hershman;E Paskett;W Salem;V Bernstein;V Stearns;J White;C Hudis;E Winer;L Carey;A Partridge;J Ligibel Obesity Jan;30(1):28-38

PMid: PMID34932888

2018

The Breast Cancer Weight Loss (BWEL) trial: Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early-stage breast cancer (Alliance A011401)

J Ligibel;W Barry;C Alfano;D Hershman;M Irwin;M Neuhouser;C Thomson;L Delahanty;E Frank;P Spears;E Paskett;JO Hopkins;V Bernstein;V Stearns;JR White;T Wadden;PJ Goodwin;L Carey;A Partridge;E Winer J Clin Oncol 36, 2018 (suppl; abstr TPS598); ASCO Annual Meeting (June 1-5, 2018, Chicago), poster

2017

Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer (A011401): Study Design and Rationale

J Ligibel;WT Barry;C Alfano;DL Hershman;M Irwin;M Neuhouser;CA Thomson;LM Delahanty;E Frank;E Spears;ED Paskett;JO Hopkins;V Bernstein;V Stearns;J White;J Hudis;E Winer;TA Wadden;PJ Woodwin NPJ Breast Cancer Sep 21;3:37

PMid: PMID28948213 | PMC number: PMC5608692

Other Clinical Trials

SWOG Clinical Trial Number
S2205
SWOG Clinical Trial Number
EAQ202

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

Research Committee(s)
Symptom Control and Quality of Life
Activated
10/28/2021
Open
Phase